A 2026 meta-analysis found no benefit of ERA or other endometrial receptivity tests in general IVF patients, with a possible improvement in live birth for RIF patients transferring untested embryos.
Endometrial receptivity array (ERA)
The Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) has issued new guidelines on 28 IVF add-ons, outlining which may help in certain situations, which lack evidence, and which should be limited to research.
Researchers in a 2023 study review the use of 27 IVF add-ons and provide recommendations by ESHRE, with only several that are recommended or could be considered for the general infertility population.
Researchers in a 2023 study combined the results of 74 studies to investigate what factors contribute to euploid live birth and miscarriage rates, identifying embryo quality, maternal age, specific diagnoses, repeat freeze/thaw, and other factors.
Researchers in a 2022 study found no difference in live birth rates in those that transferred embryos by standard timing or timing established by the ERA.
Researchers in a 2022 study performed a meta-analysis to combine the results of 8 ERA studies and found no differences in live birth, pregnancy and miscarriage rates among women who performed the ERA or didn’t.
Researchers in a 2022 study found no benefit in patients who used the ERA after transferring a single euploid, even when accounting for a history of failed transfers.
